FDA
approval
· 2013-09-13
FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
Summary
The FDA approved a supplemental application for KEPPRA (levetiracetam) submitted by UCB, Inc., under NDA021505, to update the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KEPPRA (LEVETIRACETAM)